Normothermic Extracorporeal Perfusion as a Method of Donor Heart Conditioning in Experiment
Open Access
- 2 July 2025
- journal article
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 33 (2) , 203-212
Abstract
INTRODUCTION: Extracorporeal perfusion of transplants is a promising area that is actively studied to eliminate the existing shortage of donor organs. However, the optimal parameters and duration of extracorporeal perfusion that would not lead to impairment of the morphofunctional condition of transplants, have not been sufficiently studied. AIM: To present the results of development and experimental testing of an original device for perfusion preservation of an isolated heart on the biomodel. MATERIALS AND METHODS: An original perfusion device for preserving donor hearts has been developed and experimentally tested on mature outbred male rats. During 15-hour normothermic extracorporeal perfusion of the heart in the proposed device, its rhythmic and contractile function, temperature, pH of the perfusate, pressure in the aorta, hematocrit, рО2 and рСО2 in the perfusate were studied, the content of glucose, lactate, and creatine phosphokinase (CPK) activity in perfusate samples were determined. RESULTS: During perfusion of isolated hearts, sinus rhythm was observed at a sufficient rate. Perfusate pH stayed within 7.3–7.4. Hearts were perfused at constant pressure in the aorta of 70 mm Hg in normothermic conditions (t=37°С). After stabilization of the heart function, the systolic pressure in the left ventricle was 96.0 [93.7; 98.5] mm Hg and remained without significant changes during 12 hours of perfusion; at 15 hours of perfusion, the parameter decreased by 15.0% to 82.0 [79.5; 84.2] mm Hg, p=0.01208. After stabilization of the heart function, diastolic pressure in the left ventricle was 4.0 [3.0; 5.0] mm Hg and remained without significant changes during 12 hours of perfusion; by 15 hours of perfusion, it increased 1.5 times to 6.0 [5.0; 7.0] mm Hg, p=0.0164. During the experiment, biochemical markers in the perfusate after 30 min of perfusion and stabilization were at the level of physiological values without significant dynamics within 12 hours of perfusion: glucose consumption was 80.5 [70.2; 85.5] μmol/(kg×min×mm Hg); lactate excretion — 35.7 [32.5; 44.2] μmol/(kg×min×mm Hg); CPK leakage — 95.8 [93.7; 111.3] IU/l. After 15 hours of perfusion, the level of glucose consumption by isolated hearts per unit of performed function increased significantly to 136.8 [130.5; 145.7] μmol/(kg×min×mm Hg), p=0.01208; lactate excretion and CPK leakage into the perfusate increased to 58.2 [55.7; 67.4] μmol/(kg×min×mm Hg), p=0.02144, and 229.7 [215.8; 242.4] IU/L respectively, p=0.01208. CONCLUSION: The study showed that extracorporeal perfusion of the heart in the developed device allows maintaining its viability for 12 hours in conditions maximally close to physiological ones, and also conducting dynamic assessment of the functional and metabolic state of the organ.Keywords
This publication has 13 references indexed in Scilit:
- Current state of the problem and results of ex vivo perfusion of donor heartsRussian Journal of Transplantology and Artificial Organs, 2020
- Heart transplantation as a radical method of restoring the quality of life in recipients with end-stage heart failureRussian Journal of Transplantology and Artificial Organs, 2019
- Organ preservation: from the past to the futureActa Pharmacologica Sinica, 2018
- Long distance heart transplantation: a tale of two citiesInternal Medicine Journal, 2017
- Report From the American Society of Transplantation Conference on Donor Heart Selection in Adult Cardiac Transplantation in the United StatesAmerican Journal of Transplantation, 2017
- Perfusion device for liver preservation ex vivo before transplantation: first experimental studyRussian Journal of Transplantology and Artificial Organs, 2017
- Ex vivoperfusion of the heart with the use of the Organ Care SystemEuropean Journal of Cardio-Thoracic Surgery, 2016
- Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trialThe Lancet, 2015
- Successful Heart Transplant after Ten Hours Out-of-body Time using the TransMedics Organ Care SystemHeart, Lung and Circulation, 2015
- Normothermic donor heart perfusion: current clinical experience and the futureTransplant International, 2014